Clinical applicability of diagnostic biomarkers in early‐onset cognitive impairment
Authors:
- Neus FalgàsNFNeus Falgàs
- Adrià Tort‐MerinoATAdrià Tort‐Merino
- Mircea BalasaMBMircea Balasa
- S. Borrego‐ÉcijaSBS. Borrego‐Écija
- Magdalena CastellvíMCMagdalena Castellví
- Jaume OlivesJOJaume Olives
- Beatriz BoschBBBeatriz Bosch
- Anna AntonellAAAnna Antonell
- Josep Maria AugéJAJosep Maria Augé
- Andrés PerissinottiAPAndrés Perissinotti
- 21 February 2019
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 26 (8) , 1098-1104
Abstract
Background Several diagnostic biomarkers are currently available for its clinical use in early onset cognitive impairment. The decision of which biomarker is used in each patient depends on several factors such as its predictive value or tolerability. Methods Forty subjects with early onset cognitive complaints ( p p<0.05). Biomarkers results led to diagnostic (32.5%) and treatment (32.5%) changes. All tests were well tolerated. Conclusions Biomarkers procedures are well tolerated and they have an important diagnostic/ therapeutic impact on the early onset cognitive impairment.Keywords
Funding Information
- Generalitat de Catalunya (PERIS SLT002/16/00329, SLT002/16/00408)
- Instituto de Salud Carlos III (PI14/00282)
This publication has 23 references indexed in Scilit:
- Impact of Imaging and Cerebrospinal Fluid Biomarkers on Behavioral Variant Frontotemporal Dementia Diagnosis within a Late-Onset Frontal Lobe Syndrome CohortDementia and Geriatric Cognitive Disorders, 2015
- The impact of MRI combined with visual rating scales on the clinical diagnosis of dementia: a prospective studyEuropean Radiology, 2015
- Medial temporal lobe atrophy scores translated to clinical practice: Editorial comment on ‘Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut‐offs'Journal of Internal Medicine, 2014
- Impact of cerebro-spinal fluid biomarkers of Alzheimer’s disease in clinical practice: a multicentric studyJournal of Neurology, 2013
- Imaging markers for Alzheimer diseaseNeurology, 2013
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementiaBrain, 2011
- Clinical features and APOE genotype of pathologically proven early-onset Alzheimer diseaseNeurology, 2011
- Classification of primary progressive aphasia and its variantsNeurology, 2011
- Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”Neurobiology of Aging, 1998
- Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.Journal of Neurology, Neurosurgery & Psychiatry, 1992